10-Q: Arrive AI Reports First Revenue, Nasdaq Listing, and New Capital
Quarterly Report
Arrive AI Inc. reported its first revenue in Q2 2025, alongside its Nasdaq listing and new partnerships, despite a significant increase in net loss and ongoing going concern doubts.
Summary
- Generated first-time revenue of $90,725 for the three and six months ended June 30, 2025, compared to $0 in the prior year periods.
- Net loss significantly increased to $(4,689,964) for the three months ended June 30, 2025, from $(1,459,102) in the prior year, and to $(6,668,129) for the six months ended June 30, 2025, from $(2,375,855) in the prior year.
- Operating expenses rose substantially to $4,629,628 for the three months ended June 30, 2025, up from $1,482,138, primarily due to one-time success bonuses and higher stock-based compensation.
- Cash balance increased to $607,496 as of June 30, 2025, from $129,318 at December 31, 2024, driven by financing activities.
- Accumulated deficit reached $(22,588,684) as of June 30, 2025, up from $(15,920,555) at December 31, 2024.
- Common stock began trading on the Nasdaq Stock Exchange on May 15, 2025, following the initial public offering.
- Entered into a convertible promissory note agreement with Streeterville Capital LLC for $4,330,000 (net $4,010,000) and raised $381,840 through a crowdfunding offering.
- Announced strategic partnerships and deployments with Hancock Health, Go2 Delivery, and Skye Air Mobility (India).
- Issued a new U.S. patent (US12304671B2) for heating and cooling items, bringing total U.S. patents to eight.
- Management identified substantial doubt about the ability to continue as a going concern due to accumulated deficit and net losses.
Sentiment
Score: 4
Explanation: While Arrive AI achieved its first revenue, listed on Nasdaq, and secured significant partnerships and capital, these operational and strategic positives are heavily overshadowed by a substantial increase in net losses and an explicit 'going concern' warning. The high cash burn rate and reliance on future financing indicate significant financial instability, leading to a cautious sentiment.
Positives
- Achieved first-time revenue of $90,725 for the three and six months ended June 30, 2025, indicating initial commercialization of products and services.
- Successfully completed an initial public offering and began trading common stock on the Nasdaq Stock Exchange on May 15, 2025, enhancing market visibility and access to capital.
- Secured significant financing, including a $4,330,000 convertible promissory note from Streeterville Capital LLC and $381,840 from a crowdfunding offering, improving liquidity.
- Established key partnerships and deployments with Hancock Health for biospecimen delivery, Go2 Delivery for specialty pharmacy products, and Skye Air Mobility for up to 500 Arrive Points in India, validating market interest and expanding reach.
- Issued a new U.S. patent (US12304671B2) for heating and cooling capabilities, strengthening the intellectual property portfolio to eight U.S. patents and six international patents.
- Cash balance increased significantly to $607,496 at June 30, 2025, from $129,318 at December 31, 2024, providing short-term operational funding.
Negatives
- Net loss for the three months ended June 30, 2025, increased to $(4,689,964) from $(1,459,102) in the prior year, representing a 221% increase.
- Net loss for the six months ended June 30, 2025, increased to $(6,668,129) from $(2,375,855) in the prior year, representing a 181% increase.
- Operating expenses for the three months ended June 30, 2025, surged by 212% to $4,629,628, primarily due to $1,866,531 in one-time success bonuses and $1,496,978 in stock-based compensation.
- Accumulated deficit grew to $(22,588,684) as of June 30, 2025, from $(15,920,555) at December 31, 2024, indicating continued unprofitability.
- Management has identified substantial doubt about the company's ability to continue as a going concern for the next twelve months, dependent on securing additional financing.
- Net cash used in operating activities increased to $(3,799,494) for the six months ended June 30, 2025, from $(1,353,985) in the prior year, reflecting a higher cash burn rate.
Risks
- Substantial doubt exists about the ability to continue as a going concern due to accumulated deficit of $22,588,684 and a net loss of $6,668,129 for the current period.
- Continued existence is dependent upon the ability to execute the operating plan and obtain additional debt or equity financing, with no assurance of availability or acceptable terms.
- Exposure to risks similar to other companies of similar size in the industry, including the need for successful product development.
- Competition from substitute products and services offered by larger companies.
- Challenges in protecting proprietary technology and potential patent litigation.
- Dependence on key individuals for operations and strategic direction.
- Risks associated with changes in information technology.
- Ongoing legal proceedings, including an employment action by a former CFO seeking approximately $29 million in total damages, which could be costly regardless of outcome.
- Potential for third-party infringement claims and other legal and administrative proceedings in the ordinary course of business.
- Uninsured cash balances totaling approximately $357,500 at June 30, 2025, exceeding FDIC limits.
Future Outlook
We anticipate continued revenue generation from subscription services, installation, and support, while developing new revenue models for the autonomous delivery marketplace and AI data insight monetization. Machine learning will be deployed in fourth and fifth generation Access Points (AP4 and AP5 units) for local IoT data processing and interaction models. Artificial intelligence will be used to analyze network data and leverage foundational AI models for device-based human interactions. The automated delivery marketplace (ADM) will optimize access schedules and space availability, providing critical functions for the ALM ecosystem. The first Arrive Point units are expected to be delivered to Skye Air Mobility in India by the end of 2025. We are also evaluating additional delivery routes, including drone operations, for expansion at Hancock Health in future stages.
Management Comments
- Management believes the balance of accounts receivable is fully collectable, and no allowances for credit losses have been recorded.
- Management believes the employment action allegations by Byfield Management, Inc. and Ohrn II, Richard B have no merit, and it is not possible to ascertain an exact figure for potential damages, or if any damages may be granted at all, given the facts presented before the court.
- An open, positive discussion is ongoing between counsel regarding the trademark cease and desist letter from Arrive Logistics.
Industry Context
Arrive AI operates in the rapidly evolving Autonomous Last Mile (ALM) sector, focusing on smart mailbox technology for drone, robotic, and human package delivery. The company's strategy to develop a universal ALM network of 'Arrive Points' (smart lockers and mini-cross-docks) powered by an AI-driven platform positions it to address critical infrastructure gaps in automated logistics. The partnerships with healthcare providers (Hancock Health) and logistics companies (Go2 Delivery, Skye Air Mobility) demonstrate a focus on high-value, time-sensitive deliveries and international expansion, aligning with broader industry trends towards automation, efficiency, and secure chain-of-custody in last-mile logistics. The emphasis on AI/ML for data monetization and operational platforms reflects the industry's move towards intelligent, data-driven delivery solutions.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to global benchmarks. Our differentiation is highlighted through universal compatibility, an end-to-end solution combining hardware and software with AI/ML, and early market penetration through pilot programs with significant customers like a specialty pharmaceutical delivery company.
- The company's focus on a 'smart mailbox' and 'Arrive Points' for multi-modal autonomous delivery (drones, robots, humans) represents a unique approach within the ALM industry, aiming to overcome compatibility hurdles for widespread adoption.
- The partnerships with Hancock Health for biospecimens and Go2 Delivery for specialty pharmacy products demonstrate a strategic focus on high-value, regulated segments, which may offer higher margins and less direct competition compared to general e-commerce last-mile delivery.
Legal Proceedings
- An ongoing employment action, Byfield Management, Inc. and Ohrn II, Richard B v. Dronedek Corporation, alleges breach of employment agreement, stock purchase agreement, fiduciary duties, and non-payment of salary, bonuses, and benefits, with plaintiffs alleging approximately $29 million in total damages. The company believes these allegations lack merit.
- An initial Cease and Desist letter regarding the Arrive AI trademark was received from Arrive Logistics on July 19, 2023, with an open, positive discussion ongoing between counsel.
Related Party Transactions
- A monthly license fee of $10,000 is paid to a stockholder for the use of a patent, with the agreement extended to perpetuity on March 10, 2025.
- The company rents a warehouse from an officer and shareholder for $2,250 per month on a month-to-month basis.
Stakeholder Impact
- Shareholders: Potential for future growth from new partnerships and market penetration, but significant risk from increased net losses, going concern doubts, and potential dilution from ongoing capital raises.
- Employees and Consultants: Received one-time success bonuses and stock-based compensation related to the public listing, but base salaries for some roles saw reductions due to vacancies.
- Customers: Benefit from new deployments (Hancock Health, Go2 Delivery) and expanded network (Skye Air Mobility), offering advanced autonomous delivery solutions.
- Creditors: Streeterville Capital LLC has provided significant financing through convertible notes, indicating continued support but also exposing the company to debt obligations and potential default interest if certain conditions are met.
- Regulatory Bodies: Compliance with SEC filing requirements and ongoing legal proceedings are under scrutiny.
Next Steps
- Continue to develop fourth and fifth generation Access Points (AP4 and AP5 units) for local IoT data processing, edge computing, and interaction models.
- Further develop the AI-driven platform to analyze network data and leverage foundational AI models for device-based human interactions.
- Introduce advanced capabilities for the Automated Delivery Marketplace (ADM) in AP5 development and pilot programs.
- Deliver the first Arrive Point units to Skye Air Mobility in India by the end of 2025.
- Evaluate additional delivery routes, including drone operations, for expansion at Hancock Health in future stages.
- Continue to evaluate the impact of the Taxpayer Fairness and Growth Act of 2025 on consolidated financial statements, including deferred tax assets and liabilities, and recognize required adjustments in the period of enactment.
Key Dates
| Date | Description |
|---|---|
| 2020-04-30 | Company incorporated as Dronedek Corporation. |
| 2020-06-01 | Began paying monthly license fee to a stockholder for patent use. |
| 2021-09-15 | Authorized a 2-for-1 stock split. |
| 2023-04-27 | 2023 Equity Incentive Plan created and approved by the board of directors and majority shareholder. |
| 2023-07-19 | Received an initial Cease and Desist letter on Arrive AI's trademark from Arrive Logistics. |
| 2023-07-27 | Dronedek Corporation changed its name to Arrive Technology Inc. |
| 2024-04-01 | Expanded leased office space with a new nine-month term. |
| 2024-09-27 | Arrive Technology Inc. changed its name to Arrive AI Inc. |
| 2024-11-25 | Authorized a 1-for-4 reverse stock split. |
| 2024-12-01 | Acquired three Gen 3 (AP3) Arrive Point units. |
| 2025-01-01 | ASU 2023-07 (Improvements to Reportable Segment Disclosures) became effective and was adopted. |
| 2025-03-10 | Entered into the second amendment to the Exclusive Patent License Agreement, extending the license to perpetuity. |
| 2025-03-21 | Issued a convertible promissory note with a face amount of $4,330,000 to Streeterville Capital LLC. |
| 2025-04-01 | Acquired four Gen 3 (AP3) Arrive Point units; Go2Delivery partnership began subscription revenue service; one AP3 unit placed into revenue service. |
| 2025-05-15 | Completed initial public offering, and common stock began trading on the Nasdaq Stock Exchange. |
| 2025-05-19 | Announced a two-year agreement to deploy patented Arrive Points at Hancock Health. |
| 2025-05-20 | Announced a partnership with Go2 Delivery for autonomous delivery of specialty pharmacy products. |
| 2025-06-10 | Announced the issuance of a new U.S. patent (US12304671B2) for heating and cooling items. |
| 2025-06-13 | Filed a registration statement on Form S-8 to register 1,500,000 shares of common stock under the 2023 Equity Incentive Plan. |
| 2025-06-19 | Began issuing fully vested shares under the 2023 Plan to employees, directors, and consultants (continued through July 18, 2025). |
| 2025-06-24 | Announced a new global customer, Skye Air Mobility, for deployment of up to 500 Arrive Points in India. |
| 2025-06-30 | End of the quarterly reporting period. |
| 2025-07-02 | Congress enacted the Taxpayer Fairness and Growth Act of 2025, including a corporate income tax rate reduction effective January 1, 2026. |
| 2025-07-28 | Resale registration statement on Form S-1 was declared effective by the SEC, registering up to 8,125,779 shares for resale by selling shareholders. |
| 2025-08-01 | Hancock Health recurring subscription service for access to the Arrive network and rolling robots began. |
| 2025-08-11 | Entered into Pre-Paid Purchase No. 2 with Streeterville Capital LLC, receiving $4,000,000 in proceeds for an unsecured promissory note. |
| 2025-08-14 | Date of this Quarterly Report on Form 10-Q filing. |
| 2025-12-31 | First Arrive Point units expected to be delivered to Skye Air Mobility in India. |
| 2026-01-01 | Federal corporate income tax rate reduction from 21% to 19% becomes effective. |
| 2026-12-15 | ASU 2024-03 (Income Statement Expense Disaggregation Disclosures) becomes effective for public business entities for fiscal years beginning after this date. |
| 2027-02-28 | Vehicle note payable due date. |
Recommendation
holdArrive AI Inc. is a developmental technology company that has recently achieved its first revenue and successfully listed on Nasdaq, which are positive steps. The company has also secured strategic partnerships and capital through convertible notes. However, it faces significant financial challenges, including a substantial accumulated deficit, increased net losses, and an explicit 'going concern' warning. The high operating expenses, particularly general and administrative costs driven by one-time bonuses and stock-based compensation, indicate a high cash burn. While the long-term potential in the autonomous last-mile sector is attractive, the current financial instability and reliance on further financing present considerable risks. A 'hold' recommendation reflects a cautious stance, acknowledging the operational progress and market potential while emphasizing the severe financial risks and the need for sustained, profitable revenue growth to alleviate going concern doubts. Investors should monitor future filings closely for improvements in profitability and cash flow.
Keywords
Arrive AI, drone delivery, smart mailbox, autonomous last mile, ALM, Nasdaq listing, SEC filing, 10-Q, financial results, technology, logistics, patents, capital raise, Streeterville Capital, going concern, Q2 2025 earnings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.